Delivery of Anxiety Disorder Treatment in Addictions Centers
Status: | Completed |
---|---|
Conditions: | Anxiety, Psychiatric |
Therapuetic Areas: | Psychiatry / Psychology |
Healthy: | No |
Age Range: | 18 - 60 |
Updated: | 10/28/2017 |
Start Date: | November 15, 2013 |
End Date: | November 15, 2016 |
Adaptation of CALM for Comorbid Anxiety and Substance Use Disorders
Anxiety disorders are highly prevalent among those with substance use disorders, but the
majority of addictions treatment centers provide little to no evidence-based treatment for
anxiety disorders. Furthermore, tension reduction models suggest that treating anxiety should
also improve substance use outcomes. This study is aimed at improving symptoms for people who
have substance use and anxiety problems. The study is comparing regular Intensive Outpatient
treatment for addiction to Intensive Outpatient treatment for addiction plus treatment for
anxiety disorders. Clinicians at a community addictions clinic will participate by receiving
training in delivering cognitive behavioral therapy for anxiety disorders and will deliver
the treatment to the patient participants. They will also complete some questionnaires.
Patient participants will be asked to complete a baseline assessment. Those who are eligible
will be randomly assigned to one of the two treatment groups. Those who are assigned to
addiction treatment as usual will continue their regular care at the Matrix Institute.
Participants who are assigned to also receive the anxiety treatment will be asked to
participate in 6, 90-min treatment sessions and an orientation session. All participants will
be asked to complete post-treatment and follow-up assessments. The assessments should take
approximately 1 hour, and the follow-up assessment will be completed 6 months after treatment
is over. It is hypothesized that those who get the additional anxiety disorder treatment will
show greater improvement in anxiety and substance use outcomes than those who get Intensive
Outpatient Program without the anxiety disorder treatment.
majority of addictions treatment centers provide little to no evidence-based treatment for
anxiety disorders. Furthermore, tension reduction models suggest that treating anxiety should
also improve substance use outcomes. This study is aimed at improving symptoms for people who
have substance use and anxiety problems. The study is comparing regular Intensive Outpatient
treatment for addiction to Intensive Outpatient treatment for addiction plus treatment for
anxiety disorders. Clinicians at a community addictions clinic will participate by receiving
training in delivering cognitive behavioral therapy for anxiety disorders and will deliver
the treatment to the patient participants. They will also complete some questionnaires.
Patient participants will be asked to complete a baseline assessment. Those who are eligible
will be randomly assigned to one of the two treatment groups. Those who are assigned to
addiction treatment as usual will continue their regular care at the Matrix Institute.
Participants who are assigned to also receive the anxiety treatment will be asked to
participate in 6, 90-min treatment sessions and an orientation session. All participants will
be asked to complete post-treatment and follow-up assessments. The assessments should take
approximately 1 hour, and the follow-up assessment will be completed 6 months after treatment
is over. It is hypothesized that those who get the additional anxiety disorder treatment will
show greater improvement in anxiety and substance use outcomes than those who get Intensive
Outpatient Program without the anxiety disorder treatment.
Inclusion Criteria:
- 18-60 years old
- speak English
- meet diagnostic criteria for at least one anxiety disorder
- score at least an 8 on the OASIS (see Assessments), indicating at least moderate but
clinically significant anxiety symptoms
- be enrolled in the Intensive Outpatient Program (IOP) at the Matrix Institute
(community partner)
- meet diagnostic criteria for substance abuse or dependence
Exclusion Criteria:
- have unstable medical conditions
- marked cognitive impairment
- active suicidal intent or plan
- active psychosis
- unstable Bipolar I disorder.
We found this trial at
2
sites
Los Angeles, California 90025
Principal Investigator: Kate B Taylor, Ph.D.
Click here to add this to my saved trials
Click here to add this to my saved trials